Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Combining microneedling with triamcinolone acetonide is more effective for treating alopecia areata than microneedling alone.

Tofacitinib might be used to treat hair loss.

The TrichoConcept™ line is effective for personalized hair loss treatments.

Spray B was most effective in reducing bacteria on dog hair.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

A rare skin reaction occurred when a man took paracetamol, causing a new rash in an area already affected by hair loss.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Dextroamphetamine may help treat alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.